Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Aldeyra reports positive Phase llb results from reproxalap trial

Dry eye disease is estimated to affect around 20 million people in the US. Credit: DraconianRain.

Go Top